Synaptogenix (NASDAQ:SNPX) Issues Quarterly Earnings Results

Synaptogenix (NASDAQ:SNPX) released its quarterly earnings data on Thursday. The company reported ($4.36) EPS for the quarter, Zacks reports.

Synaptogenix Price Performance

Shares of SNPX stock traded up $0.03 during mid-day trading on Thursday, hitting $2.67. The company had a trading volume of 8,365 shares, compared to its average volume of 31,144. Synaptogenix has a 52-week low of $2.15 and a 52-week high of $6.22. The stock’s 50 day moving average price is $2.97 and its 200-day moving average price is $3.03.

About Synaptogenix

Synaptogenix, Inc operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It also evaluates therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease.